Position in AMGN
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$31,853,523
+$5,293,423 QoQ
Shares Held
87,964
+16.5% QoQ
Ownership
0.016%
of shares outstanding
% of Portfolio
0.22%
of 13F equity value
Holder Rank
#288
of 3,149 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 53%
Shared 0%
None 47%
Common Shares in AMGN Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026SILVERCREST ASSET MANAGEMENT GROUP LLC holds $298,590,573 across 11 Drug Manufacturers - General names. AMGN ranks #3 (10.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
546,930 | $138,903,812 | |
| 2 | MRK |
Merck & Co., Inc.
|
253,643 | $32,593,125 | |
| 3 | AMGN |
Amgen Inc
This page
|
87,964 | $31,853,523 | |
| 4 | ABBV |
AbbVie Inc.
|
108,246 | $27,239,023 | |
| 5 | AZN |
Astrazeneca PLC
|
134,020 | $25,412,872 | |
| 6 | GSK |
GSK plc
|
313,984 | $16,459,041 | |
| 7 | LLY |
ELI LILLY & Co
|
13,666 | $16,391,411 | |
| 8 | BMY |
Bristol Myers Squibb Co
|
66,843 | $3,851,493 |
All Filings in AMGN
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $31,853,523 | 87,964 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $26,560,100 | 75,487 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $27,798,438 | 84,930 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $23,975,712 | 84,960 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $24,875,377 | 89,092 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $33,323,076 | 106,959 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $30,938,749 | 118,703 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $71,843,485 | 222,971 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $71,115,494 | 227,606 | Shares | Sole | 2024-08-15 | |
| 2024-03-31 | $65,826,619 | 231,523 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $66,591,376 | 231,204 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $65,206,013 | 242,618 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $56,705,240 | 255,406 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $72,114,508 | 298,302 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $80,047,156 | 304,779 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $69,167,371 | 306,865 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $75,736,613 | 311,289 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $74,902,293 | 309,744 | Shares | Sole | 2022-05-16 | |
| 2021-12-31 | $68,915,509 | 306,332 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $76,664,577 | 360,520 | Shares | Sole | 2021-11-15 | |
| 2021-06-30 | $88,839,074 | 364,468 | Shares | Other | 2021-08-16 | |
| 2021-03-31 | $89,801,002 | 360,922 | Shares | Sole | 2021-05-17 | |
| 2020-12-31 | $70,338,275 | 305,925 | Shares | Sole | 2021-02-16 | |
| 2020-09-30 | $91,490,483 | 359,972 | Shares | Sole | 2020-11-16 | |
| 2020-06-30 | $85,965,780 | 364,478 | Shares | Sole | 2020-08-14 | |
| 2020-03-31 | $74,146,266 | 365,739 | Shares | Sole | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||